With the approval of the China Securities Regulatory Commission, Guangdong Biolight Meditech Co., Ltd. initially and publicly offered 10,500,000 common shares, and these shares were listed in the ChiNext Market at the Shenzhen Stock Exchange on 19 July 2011.
As legal counsel to Guangdong Biolight Meditech Co., Ltd., Llinks advised on all aspects of this initial public offering and listing.